We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

One Year Later: CRISPR Success in Duchenne Muscular Dystrophy Model

News   Feb 19, 2019 | Original story from Duke University

 
One Year Later: CRISPR Success in Duchenne Muscular Dystrophy Model

These images highlight the stark contrast between mouse models of untreated Duchenne muscular dystrophy (left) and those treated with a CRISPR-based genetic therapy after one year (right). On the right, green indicates a higher level of dystrophin gene expression. The dark spots in the inset show T cells from these mice responding to the bacterial Cas9 protein, indicating the presence of an immune response to the therapy. Credit: Charles Gersbach, Duke University

 
 
Advertisement
 

RELATED ARTICLES

Blood Markers of Fitness Identified

News

A simple blood test may be able to determine how physically fit you are, according to a new study conducted by scientists at the Stanford University School of Medicine.

READ MORE

Scientists Develop a Bioelectronic Device That Can Regulate Genes From Outside the Body

News

A team of researchers led by Martin Fussenegger, ETH Professor of Biotechnology and Bioengineering at the Department of Biosystems Science and Engineering in Basel, have published a study which is the first to explore how gene expression can be directly actived and regulated using electrical signals.

READ MORE

Markers in Blood Can Help Identify Risk for Complications After Mild TBI

News

Molecules released into the blood following mild traumatic brain injury may be indicators of neuronal damage associated with complications, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE